Welcome to our dedicated page for Hca Healthcare SEC filings (Ticker: HCA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
HCA Healthcare’s sheer scale—hundreds of hospitals, thousands of beds, and billions in Medicare reimbursements—means its SEC disclosures overflow with complex details about payer mix, same-facility admissions, malpractice reserves, and regulatory audits. Finding the one line on outpatient surgery margins or the note on cyber breaches can feel impossible.
Stock Titan rescues your schedule. Our AI digests every HCA Healthcare annual report 10-K simplified, flags shifts in reimbursement rates inside the HCA Healthcare quarterly earnings report 10-Q filing, and delivers HCA Healthcare Form 4 insider transactions real-time alerts the second they hit EDGAR. Curious about sudden executive sales? The platform highlights HCA Healthcare executive stock transactions Form 4. Need context on a facility divestiture? We attach plain-English notes to the latest HCA Healthcare 8-K material events explained. Our AI-powered summaries translate technical accounting into clear language—ideal for understanding HCA Healthcare SEC documents with AI rather than wading through footnotes.
Investors use these insights to monitor reimbursement exposure, benchmark occupancy trends, and compare segment margins quarter over quarter. Whether you’re researching HCA Healthcare proxy statement executive compensation before a vote or seeking an HCA Healthcare earnings report filing analysis to project free cash flow, every document is indexed, searchable, and updated in real time. That includes the must-track HCA Healthcare insider trading Form 4 transactions for pattern analysis. Complex filings, clarified—so you can act before the market does.
HCA Healthcare, Inc. (HCA) disclosure shows a proposed sale of 3,836 common shares through Merrill Lynch on the New York Stock Exchange with an aggregate market value of $1,606,670.20 and an approximate sale date of 09/08/2025. The shares were acquired on 09/04/2025 via exercises of Stock Appreciation Rights (2,782 and 1,054 shares) and payment was recorded as compensatory.
The filer reports no securities sold in the prior three months and includes the standard representation that the seller is not aware of undisclosed material adverse information. Several identifying fields for the filer and issuer (CIK, names, addresses) are not populated in the provided content.
Michael S. Cuffe, Executive Vice President and Chief Clinical Officer of HCA Healthcare (HCA), reported transactions under a Rule 10b5-1 plan adopted May 6, 2025. On 09/04/2025 he exercised 10,920 stock appreciation rights at an exercise price tied to $173.12 and those underlying 10,920 common shares were issued. On 09/04/2025 he sold 7,084 shares at $411.59 and on 09/08/2025 he sold 3,836 shares at $418.84, which together equal the 10,920 shares from the SAR exercise. Following these transactions his reported beneficial ownership stood at 31,502.9017 shares, which includes 2,595.9017 shares held under the company's employee stock purchase plans. The SARs vested in four equal annual installments beginning February 3, 2022.
HCA Healthcare has filed a Form S-8 to register an additional 13,150,000 shares of common stock ($0.01 par value) under its 2020 Stock Incentive Plan for Key Employees. This amendment to the plan became effective April 24, 2025.
Key details of the filing:
- Registration is for additional shares authorized under the amended 2020 Stock Plan
- Company is classified as a large accelerated filer
- Filing incorporates by reference multiple documents including the 2024 Annual Report, Q1 2025 Quarterly Report, and recent Current Reports
The filing includes executive signatures from key leadership including Samuel N. Hazen (CEO), Michael A. Marks (CFO), and Thomas F. Frist III (Chairman). This stock plan registration indicates HCA Healthcare's continued investment in employee compensation and retention through equity-based incentives.
FAQ
What is the current stock price of Hca Healthcare (HCA)?
What is the market cap of Hca Healthcare (HCA)?
